Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEarly Phase (Phase 0 or I) human studies

Prospective Comparison of mpMRI and 18F-FMAU PET/CT in Image-Guided Prostate Biopsy for Detection of Cancer: Preliminary Results

Hossein Jadvar, Passant Mohamed, Darryl Hwang, Kai Chen and Andre Abreu
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2534;
Hossein Jadvar
1University of Southern California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Passant Mohamed
1University of Southern California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darryl Hwang
1University of Southern California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai Chen
1University of Southern California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre Abreu
1University of Southern California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2534

Introduction: We aimed to evaluate the potential complementary utility of PET with the cellular proliferation biomarker, [18F]-2’-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU), in localization of sites for image-guided biopsy in men with suspected prostate cancer.

Methods: 17 men with suspected prostate cancer scheduled to undergo standard transrectal ultrasound (TRUS) guided prostate gland biopsy were prospectively recruited in this Instituitional Review Board approved investigation. Patients underwent standard of care mpMRI and consented to have additional investigational PET/CT performed 60 min after intravenous injection of 10 mCi 18F-FMAU. PIRADS v2.1 scores of 3 and higher on mpMRI and visually discernable focal radiotracer localization higher than background prostate uptake level were considered for biopsy. PET/CT and mpMRI were fused with TRUS images for real-time hybrid image-based targeting of biopsy needle in addition to standard 12-core biopsy. All harvested biopsy tissues were examined for presence of tumor. If imaging was positive in a sextant region, this finding was considered true positive if the biopsy was positive for presence of tumor regardless of whether the tissue was obtained through standard grid or image-guidance in that same sextant region.

Results: Tissue samples obtained from 20 image-guided biopsies were examined histologically: 9 benign, 6 Gleason Score (GS) 3+3 (ISUP grade 1), and 5 GS 3+4 (ISUP grade 2), with range of biopsy core tumor involvement of 5%-50% and tumor length of 1-10 mm. For ISUP grade 1, 18F-FMAU PET/CT was TP in 3, and FN in 3, while mpMRI was TP in 1 and FN in 4. For ISUP grade 2, 18F-FMAU PET/CT was TP in 3, and FP in 2, while mpMRI was 5 TP. Findings of mpMRI and 18F-FMAU PET/CT were concordant in 10 (both imaging modalities TP in 3, TN in 1, FP in 4, and FN in 2) and discordant in 10. Overall, mpMRI resulted in 6 TP, 4 TN, 5 FP, and 5 FN. 18F-FMAU PET/CT findings were 6 TP, 2 TN, 9 FP, and 3 FN. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for detection of prostate cancer were 54.5%, 44.4%, 54.5%, 44.4%, and 50% for mpMRI, and 66.6%, 18.2%, 40%, 40%, and 40% for 18F-FMAU PET/CT, respectively.

Conclusions: 18F-FMAU PET/CT may complement mpMRI by enhancing sensitivity in detecting prostate cancer. Further post-hoc quantitative data analysis will be performed to optimize the PET image evaluation scheme for improving the diagnostic performance in localizing candidate sites for image-guided biopsy in men with suspected prostate cancer.

Supported by grants R21-EB017568 and P30-CA014089 from the U.S. National Institutes of Health.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prospective Comparison of mpMRI and 18F-FMAU PET/CT in Image-Guided Prostate Biopsy for Detection of Cancer: Preliminary Results
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prospective Comparison of mpMRI and 18F-FMAU PET/CT in Image-Guided Prostate Biopsy for Detection of Cancer: Preliminary Results
Hossein Jadvar, Passant Mohamed, Darryl Hwang, Kai Chen, Andre Abreu
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2534;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prospective Comparison of mpMRI and 18F-FMAU PET/CT in Image-Guided Prostate Biopsy for Detection of Cancer: Preliminary Results
Hossein Jadvar, Passant Mohamed, Darryl Hwang, Kai Chen, Andre Abreu
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2534;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • First-in-human evaluation of 68Ga-FAP-2286, a fibroblast activation protein targeted radioligand
  • Defining the optimal ligand mass dose in systemic targeted radionuclide therapy
  • Features of 18F-NOTA-FAPI-04 PET/CT for predicting pathological response to neoadjuvant chemoradiotherapy in esophageal cancer
Show more Early Phase (Phase 0 or I) human studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire